IPCA Laboratories has reportedly completed redemption of 2 formulation plants Pithampur and Piparia. The undergoing verification of these two plants was held by third party consultants. The verification process of these 2 plants is likely to be completed by March 2017.
Ipca Laboratories is engaged in manufacturing of active pharmaceutical ingredients and formulations. It operates in 110 countries and its export accounts for 50% of the company’s income. Worldwide the company is one of the largest suppliers of APIs and intermediates. The company holds leadership position in Anti-malarial and Rheumatoid Arthritis area.
